دورية أكاديمية
Variation in Secondary Prevention of Coronary Heart Disease: The INTERASPIRE Study.
| العنوان: | Variation in Secondary Prevention of Coronary Heart Disease: The INTERASPIRE Study. |
|---|---|
| المؤلفون: | McEvoy JW; University of Galway School of Medicine and National Institute for Prevention and Cardiovascular Health, Moyola Lane, Newcastle, Galway H91 FF68, Ireland., Jennings C; University of Galway School of Medicine and National Institute for Prevention and Cardiovascular Health, Moyola Lane, Newcastle, Galway H91 FF68, Ireland., Kotseva K; University of Galway School of Medicine and National Institute for Prevention and Cardiovascular Health, Moyola Lane, Newcastle, Galway H91 FF68, Ireland.; Imperial College Healthcare NHS Trust, London, UK., De Bacquer D; Department of Public Health and Primary Care, Ghent University, Gent, Belgium., De Backer G; Department of Public Health and Primary Care, Ghent University, Gent, Belgium., Erlund I; Biomarkers, Department of Government Services, Finnish Institute for Health and Welfare, Finland., Vihervaara T; Biomarkers, Department of Government Services, Finnish Institute for Health and Welfare, Finland., Lip GYH; Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK., Ray K; Department of Public Health and Primary Care, Imperial College London, UK., Rydén L; Department of Medicine Solna, Karolinska Institutet, 171 76 Stockholm, Sweden., Abreu A; Faculty of Medicine, University of Lisbon (FMUL), University Hospital of Santa Maria, CHULN, Av. Egas Moniz, 1649-082, Lisbon, Portugal., Almahmeed W; Cleveland Clinic Abu Dhabi, Al Mariah Island, Abu Dhabi, United Arab Emirates., Meidian Ambari A; National Cardiovascular Center Harapan Kita, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, West Jakarta, Jakarta, Indonesia., Ge J; Fudan University Zhongshan Hospital, Floor 15, Building 16, No. 1609 Xietu Road, Xuhui District, Shanghai 200000, China., Hasan-Ali H; Cardiovascular Medicine Department, Assiut University Heart Hospital, 71111, Assiut, Egypt., Huo Y; Peking University First Hospital, Department of Cardiology, Institute of Cardiovascular Disease, No. 8 XiShiku Street, Xicheng District, Beijing 100034, China., Jankowski P; Department of Internal Medicine and Geriatric Cardiology, Centre of Postgraduate Medical Education, 231 Czerniakowska St, 00-416 Warsaw, Poland., Jimenez RM; Philippine Heart Association & St. Luke's Medical Center, Global City, Rizal Avenue Corner 32nd Street, Taguig City, Metro Manila, Philippines., Li Y; Department of Internal Medicine (Cardiology), Fudan University Huashan Hospital, 12 Wulumuqi Zhong Rd, Shanghai 200040, China., Zuhdi ASM; University Malaya Medical Centre, Cardiology Unit, Department of Medicine, 59100 Kuala Lumpur, Malaysia., Makubi A; Muhimbili Orthopedic Institute (MOI), P.O BOX 65474, Dar es salaam, Tanzania., Mbakwem AC; Department of Medicine, College of Medicine, University of Lagos, Idi Araba, Lagos, Nigeria., Mbau L; Kenya Cardiac Society, P.O Box, 8038-00100, Nairobi, Kenya., Navarro Estrada JL; Italian Hospital of Buenos Aires, Gascon 450 (1181) Buenos Aires, Argentina., Ogah OS; Cardiology Unit, Department of Medicine, University of Ibadan, University College Hospital, Ibadan, Nigeria., Ogola EN; Department of clinical medicine and therapeutics, University of Nairobi, P. O. Box 19676, Nairobi, Kenya., Quintero-Baiz A; Faculty of Health Sciences, University Simon Bolivar, Cra 50 # 80 - 216 office 109 Barranquilla, Colombia., Sani MU; Department of Medicine, Bayero University Kano & Aminu Kano Teaching Hospital, PMB 3452, Kano 700223, Kano State, Nigeria., Sosa Liprandi MI; Cardiology Service, University Hospital Sanatorio Güemes, Francisco Acuna de Figueroa 1240, (Zip code 1180), Buenos Aires, Argentina., Tan JWC; National Heart Centre Singapore, Singapore; (2) Duke-NUS Medical School, Singapore; (3) Department of Cardiology, Sengkang General Hospital, Singapore, Singapore, National Heart Centre, Singapore, 5 Hospital Dr, Singapore 169609, Singapore., Urina Triana MA; Faculty of Health Sciences, Universidad Simon Bolivar, Carrera 59 # 59-65, Barranquilla, Colombia., Yeo TJ; National University Heart Centre Singapore and National University Hospital, National University Health System (NUHS) Tower Block, 1E Lower Kent Ridge Road, Level 9, Cardiac Department, Singapore 119228, Singapore., Ganly S; University of Galway School of Medicine and National Institute for Prevention and Cardiovascular Health, Moyola Lane, Newcastle, Galway H91 FF68, Ireland., Adamska A; University of Galway School of Medicine and National Institute for Prevention and Cardiovascular Health, Moyola Lane, Newcastle, Galway H91 FF68, Ireland., Wood D; University of Galway School of Medicine and National Institute for Prevention and Cardiovascular Health, Moyola Lane, Newcastle, Galway H91 FF68, Ireland.; National Heart and Lung Institute, Imperial College London, Guy Scadding Building, Cale Street, London, SW3 6LY, UK. |
| المصدر: | European heart journal [Eur Heart J] 2024 Aug 30. Date of Electronic Publication: 2024 Aug 30. |
| Publication Model: | Ahead of Print |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Oxford University Press Country of Publication: England NLM ID: 8006263 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-9645 (Electronic) Linking ISSN: 0195668X NLM ISO Abbreviation: Eur Heart J Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2005- : Oxford : Oxford University Press Original Publication: London, Saunders [etc.] |
| مستخلص: | Background and Aims: INTERASPIRE is an international study of coronary heart disease (CHD) patients, designed to measure if guideline standards for secondary prevention and cardiac rehabilitation are being achieved in a timely manner. Methods: Between 2020-2023, adults hospitalized in the preceding 6-24 months with incident or recurrent CHD were sampled in 14 countries from all 6 World Health Organization regions and invited for a standardized interview and examination. Direct age and sex standardization was used for country-level prevalence estimation. Results: Overall, 4548 (21.1% female) CHD patients were interviewed a median of 1.05 (interquartile range 0.76-1.45) years after index hospitalization. Among all participants, 24% were obese (40% centrally). Only 38.5% achieved a blood pressure (BP) <130/80 mmHg and 19.2% a low-density lipoprotein cholesterol (LDL-C) of <1.4 mmol/l. Of those smoking at hospitalization, 48% persisted at interview. Of those with known diabetes, 56% achieved glycated hemoglobin (HbA1c) of <7.0%. A further 9.8% had undetected diabetes and 26.9% impaired glucose tolerance. Females were less likely to achieve targets: BP (females 37.4% males 38.6%), LDL-C (females 13.7% males 18.6%) and HbA1c in diabetes (females 47.7% males 57.5%). Overall, just 9.0% (inter-country range 3.8%-20.0%) reported attending cardiac rehabilitation and 1.0% (inter-country range 0.0%-2.4%) achieved the study definition of optimal guideline adherence. Conclusions: INTERASPIRE demonstrates inadequate and heterogeneous international implementation of guideline standards for secondary prevention in the first year after CHD hospitalization, with geographic and sex disparity. Investment aimed at reducing between-country and between-individual variability in secondary prevention will promote equity in global efforts to reduce the burden of CHD. (© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.) |
| فهرسة مساهمة: | Keywords: Coronary heart disease; Global health equity; Guideline implementation; Observational research; Secondary prevention |
| تواريخ الأحداث: | Date Created: 20240830 Latest Revision: 20240830 |
| رمز التحديث: | 20240902 |
| DOI: | 10.1093/eurheartj/ehae558 |
| PMID: | 39212219 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1522-9645 |
|---|---|
| DOI: | 10.1093/eurheartj/ehae558 |